You just read:

RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis

News provided by

RepliCel Life Sciences Inc.

Jun 30, 2015, 07:00 ET